Search bioRxiv⌕ Search

Biology subjects

Trivedi, I.

Publications and source records attributed to Trivedi, I..

2 recordsLinked to original sources

Functional divergence of the repressors of photomorphogenesis SPA2 and SPA3 during Arabidopsis seedling deetiolation

The COP1/SPA ubiquitin ligase is a key repressor of photomorphogenesis that is inactivated by photoreceptors to initiate light signalling. The four SPA proteins (SPA1-SPA4) confer functional specificity to COP1 during plant growth, yet the underlying molecular mechanisms remain unclear. Here, we used a domain-swap approach in transgenic seedlings to address the functional divergence of SPA2 and SPA3. We show that the respective N-terminal kinase domain determines the contrasting protein stabilities of SPA2 and SPA3 in light-grown seedlings. The instability of SPA2 correlates with a specific ability of the SPA2 N-terminal domain to bind phytochrome A in the light, suggesting that phytochrome A promotes the CUL4DET1/COP1-dependent degradation of SPA2 but not of SPA3. We uncover that the coiled-coiled and WD-repeat domains of SPA2 and SPA3 substantially differ in their activity in repression of photomorphogenesis, with those of SPA2 being more active repressors than those of SPA3. Thus, SPA2 combines a potent repressor activity with light-induced instability. We conclude that the evolution of SPA2 instability in response to light counterbalances its inherent strong repressor activity, thereby allowing seedling etiolation in darkness followed by rapid reduction in COP1 activity through SPA2 degradation upon light-exposure as seedlings emerge from soil to initiate photosynthetic growth. HighlightThe repressor of light signaling SPA2 combines a phytochrome A-interacting instability domain with a potent repressor domain to allow greatly contrasting activities of COP1 in skoto- and photomorphogenesis.

plant biology↗

Dopamine and serotonin transients predict depressive symptom relief following deep brain stimulation of human subcallosal cingulate cortex

Recent advances in deep brain stimulation (DBS) of the subcallosal cingulate (SCC) show promise in mitigating the symptoms of treatment-resistant depression (TRD) in humans1-3. Monoamines, such as dopamine and serotonin, mediate the effects of pharmacological treatments of depression. However, their roles in recovery following DBS remain elusive, largely due to technical limitations of measuring these neurotransmitters in the living human brain. Here, by leveraging machine learning-enhanced electrochemistry4-7, we show that dopamine and serotonin signaling following DBS to the SCC predicted later depressive symptom relief in humans with TRD. We found that both dopamine and serotonin levels increased following subtherapeutic intraoperative SCC stimulation, with each neurotransmitter showing selective responses to distinct decision-making tasks. Furthermore, acute dopamine increases predicted later mood improvements during a social decision-making task, while serotonin enhancement predicted faster responses during a non-social learning task longitudinally. Critically, changes in dopamine and serotonin levels during the social decision-making task jointly predicted depressive symptom remission at 6-month follow-up. These findings illustrate the contribution of both dopamine and serotonin signaling in predicting behavioral improvement and depressive symptom remission in humans with TRD. Such neurochemical plasticity may serve as potential mechanistic biomarkers for SCC DBS mechanism and TRD treatment response. Significance statementO_LIDopamine and serotonin levels increased following acute DBS to the SCC in humans. C_LIO_LIAcute dopamine and serotonin changes predicted later mood and response speed changes. C_LIO_LISustained TRD recovery was predicted by acute increases in both dopamine and serotonin estimates. C_LI

neuroscience↗